Nemaura Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Nemaura Medical generated cash of -$8,451,781, which is less than the previous year. Cash used in financing activities reached the amount of $2,082,117 last year. Net change in cash is therefore -$7,644,098.
Cash Flow
| 2014 | 1.50M | -97.88K | 265.48K |
|---|---|---|---|
| 2015 | -1.43M | -6.74K | 0 |
| 2016 | -1.20M | -87.56K | 10.29M |
| 2017 | -1.19M | -6.30M | 0 |
| 2018 | -2.13M | 1.94M | 0 |
| 2019 | -3.56M | 4.40M | 2.04M |
| 2020 | -3.44M | -211.03K | 97.23K |
| 2021 | -5.99M | -836.44K | 37.98M |
| 2022 | -6.50M | -956.48K | -6.36M |
| 2023 | -8.45M | -539.21K | 2.08M |
NMRD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 17.74M | 31.86M | 106.10K | 3.74M | 822.33K | 911.35K | 9.40M | 354.74K | 1.87M | 200.48K |
Operating activities | ||||||||||
Net income | -14.14M | -13.88M | -6.25M | -4.16M | -4.45M | -1.82M | -1.55M | -1.53M | -1.31M | -586.23K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 444.17K | 229.81K | 98.07K | 54.84K | 33.40K | 29.25K | 20.43K | 17.40K | 7.55K | 5.09K |
Stock-based compensation expense | 0 | 220.91K | 113.17K | 565.03K | 429.61K | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 220.91K | 113.17K | 565.03K | 429.61K | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 576.91K | -250.09K | -681.29K | 0 | -2.88M | 0 | 0 | 0 | 0 | 0 |
Inventories | -1.74M | -637.14K | -564.31K | -258.52K | -37.39K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 190.33K | -117.38K | -39.91K | 138.48K | 98.11K | -31.24K | 2.52K | -31.27K | 117.22K | 8.26K |
Cash generated by operating activities | -8.45M | -6.50M | -5.99M | -3.44M | -3.56M | -2.13M | -1.19M | -1.20M | -1.43M | 1.50M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -6.22M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -376.17K | -956.48K | -836.44K | -211.03K | -79.99K | -45.26K | -79.58K | -87.56K | -92.20K | -12.42K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -539.21K | -956.48K | -836.44K | -211.03K | 4.40M | 1.94M | -6.30M | -87.56K | -6.74K | -97.88K |
Financing activities | ||||||||||
Common Stock Issued | 8.39M | 3.11M | 15.75M | 152.49K | 2.47M | 0 | 0 | 10M | 0 | 265.48K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -5.57M | -12.4M | -600K | -40.89K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 2.08M | -6.36M | 37.98M | 97.23K | 2.04M | 0 | 0 | 10.29M | 0 | 265.48K |
Net Change In Cash | -7.64M | -14.11M | 31.75M | -3.63M | 2.91M | -89.02K | -8.49M | 9.04M | -1.51M | 1.67M |
Cash at end of period | 10.10M | 17.74M | 31.86M | 106.10K | 3.74M | 822.33K | 911.35K | 9.40M | 354.74K | 1.87M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |